Onyx Pharmaceuticals Inc

CIK 1012140 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Onyx Pharmaceuticals Inc.

Recent SEC filings

FiledFormAccession number
Dec 16, 2013CT ORDER9999999997-13-017296
Oct 11, 201315-12G0001193125-13-397900
Oct 11, 201315-12G0001193125-13-397885
Oct 3, 201340001181431-13-052510
Oct 3, 201340001181431-13-052528
Oct 3, 201340001181431-13-052509
Oct 3, 201340001181431-13-052513
Oct 3, 201340001181431-13-052514
Oct 3, 201340001181431-13-052511
Oct 3, 201340001181431-13-052530
Oct 3, 201340001181431-13-052518
Oct 3, 201340001181431-13-052521
Oct 3, 201340001181431-13-052505
Oct 3, 201340001181431-13-052504
Oct 3, 201340001181431-13-052519
Oct 3, 201340001181431-13-052512
Oct 3, 201340001181431-13-052507
Oct 3, 201340001181431-13-052525
Oct 1, 2013SC 14D9/A0001193125-13-385868
Oct 1, 20138-K0001193125-13-387156
Oct 1, 2013SC TO-T/A0001193125-13-385864
Oct 1, 2013POS AM0001193125-13-387189
Oct 1, 2013POS AM0001193125-13-387199
Oct 1, 2013POSASR0001193125-13-387179
Oct 1, 2013POSASR0001193125-13-387183